Compare TR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TR | RXRX |
|---|---|---|
| Founded | 1896 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | N/A | 2021 |
| Metric | TR | RXRX |
|---|---|---|
| Price | $37.61 | $4.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 127.2K | ★ 21.7M |
| Earning Date | 10-23-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 0.79 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $729,620,000.00 | $43,689,000.00 |
| Revenue This Year | N/A | $7.79 |
| Revenue Next Year | N/A | $27.32 |
| P/E Ratio | $29.21 | ★ N/A |
| Revenue Growth | ★ 0.34 | N/A |
| 52 Week Low | $28.67 | $3.79 |
| 52 Week High | $44.27 | $12.36 |
| Indicator | TR | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 43.16 |
| Support Level | $36.93 | $4.61 |
| Resistance Level | $38.51 | $5.09 |
| Average True Range (ATR) | 0.84 | 0.26 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 22.41 | 23.28 |
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.